Degludec insulin: A novel basal insulin

This paper reviews a novel insulin analogue, degludec, which has the potential to emerge as an ideal basal insulin. It reviews the limitations of existing basal insulin and analogues, and highlights the need for a newer molecule. The paper discusses the potential advantages of degludec, while review...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalra, Sanjay, Unnikrishnan, Ambika Gopalakrishnan, Baruah, Manash, Kalra, Bharti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications 2011
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3152187/
https://www.ncbi.nlm.nih.gov/pubmed/21847448
http://dx.doi.org/10.4103/2230-8210.83056
_version_ 1782209744996401152
author Kalra, Sanjay
Unnikrishnan, Ambika Gopalakrishnan
Baruah, Manash
Kalra, Bharti
author_facet Kalra, Sanjay
Unnikrishnan, Ambika Gopalakrishnan
Baruah, Manash
Kalra, Bharti
author_sort Kalra, Sanjay
collection PubMed
description This paper reviews a novel insulin analogue, degludec, which has the potential to emerge as an ideal basal insulin. It reviews the limitations of existing basal insulin and analogues, and highlights the need for a newer molecule. The paper discusses the potential advantages of degludec, while reviewing its pharmacologic and clinical studies done so far. The paper assesses the potential role of insulin degludec and degludec plus in clinical diabetes practice.
format Online
Article
Text
id pubmed-3152187
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-31521872011-08-16 Degludec insulin: A novel basal insulin Kalra, Sanjay Unnikrishnan, Ambika Gopalakrishnan Baruah, Manash Kalra, Bharti Indian J Endocrinol Metab Review Article This paper reviews a novel insulin analogue, degludec, which has the potential to emerge as an ideal basal insulin. It reviews the limitations of existing basal insulin and analogues, and highlights the need for a newer molecule. The paper discusses the potential advantages of degludec, while reviewing its pharmacologic and clinical studies done so far. The paper assesses the potential role of insulin degludec and degludec plus in clinical diabetes practice. Medknow Publications 2011-07 /pmc/articles/PMC3152187/ /pubmed/21847448 http://dx.doi.org/10.4103/2230-8210.83056 Text en © Indian Journal of Endocrinology and Metabolism http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Kalra, Sanjay
Unnikrishnan, Ambika Gopalakrishnan
Baruah, Manash
Kalra, Bharti
Degludec insulin: A novel basal insulin
title Degludec insulin: A novel basal insulin
title_full Degludec insulin: A novel basal insulin
title_fullStr Degludec insulin: A novel basal insulin
title_full_unstemmed Degludec insulin: A novel basal insulin
title_short Degludec insulin: A novel basal insulin
title_sort degludec insulin: a novel basal insulin
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3152187/
https://www.ncbi.nlm.nih.gov/pubmed/21847448
http://dx.doi.org/10.4103/2230-8210.83056
work_keys_str_mv AT kalrasanjay degludecinsulinanovelbasalinsulin
AT unnikrishnanambikagopalakrishnan degludecinsulinanovelbasalinsulin
AT baruahmanash degludecinsulinanovelbasalinsulin
AT kalrabharti degludecinsulinanovelbasalinsulin

Ejemplares similares